- €2.16bn
- €4.99bn
- €1.74bn
- 26
- 84
- 84
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Other Revenue | |||||
Total Revenue | 1,316 | 1,131 | 1,277 | 1,679 | 1,736 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,093 | 982 | 964 | 1,321 | 1,374 |
Operating Profit | 224 | 149 | 313 | 357 | 363 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 202 | 128 | 291 | 328 | 329 |
Provision for Income Taxes | |||||
Net Income After Taxes | 147 | 82.9 | 224 | 241 | 241 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 147 | 82.9 | 224 | 240 | 241 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 147 | 82.9 | 224 | 240 | 241 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.981 | 0.543 | 1.51 | 1.61 | 1.61 |
Dividends per Share |